Interferon-alpha, but not the ABL-kinase inhibitor imatinib (STI571), induces expression of myeloblastin and a specific T-cell response in chronic myeloid leukemia.
Burchert A, Wölfl S, Schmidt M, Brendel C, Denecke B, Cai D, Odyvanova L, Lahaye T, Müller M, Berg T, Gschaidmeier H, Wittig B, Hehlmann R, Hochhaus A, Neubauer A. Interferon-alpha, but not the ABL-kinase inhibitor imatinib (STI571), induces expression of myeloblastin and a specific T-cell response in chronic myeloid leukemia. Blood 2002; 101:259-64.
Jun 28, 2002
Interferon-alpha, but not the ABL-kinase inhibitor imatinib (STI571), induces expression of myeloblastin and a specific T-cell response in chronic myeloid leukemia.
Jun 28, 2002
Blood 2002; 101:259-64
Burchert Andreas, Wölfl Stefan, Schmidt Manuel, Brendel Cornelia, Denecke Barbara, Cai Dali, Odyvanova Larissa, Lahaye Tanja, Müller Martin, Berg Thomas, Gschaidmeier Harald, Wittig Burghardt, Hehlmann Rüdiger, Hochhaus Andreas, Neubauer Andreas
more
